Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
| Disease Info Index | ||||||||||||||||||||||||||
|
|
Prostate Cancer
Drugs For Prostate Cancer
abarelix
abiraterone acetate
bicalutamide
buserelin
cabazitaxel
capromab pendetide
cisplatin
cyclosporine
cyproterone tablet
cytarabine
More Drugs
Page Options
Prostate Cancer / Cancer of Prostate
3.99
/5
Comments : 1
| |||
About Prostate Cancer |
|||
Text 
Prostate cancer is the second most common cancer in men after lung cancer. It usually affects men over the age of fifty years. It is estimated that approximately 1 in 5 men will be diagnosed with prostate cancer during their lifetime, however only 1 in 33 will die of this disease. Prostate cancer usually does not give rise to any symptoms till it is in advanced stages. Hence in many countries men over the age of fifty, who go for routine health check-ups are also advised to get checked for this cancer. A clinical test in the doctors surgery called digital rectal examination or DRE can pick up some of these cancers.
Unlike other cancers the natural history of prostate cancer is different. Some prostate cancer are indolent and slow growing and may take years before they manifest or become sinister; whereas another group are more aggressive - like any other cancers and require urgent treatment. "Women with breast cancer almost universally die from it within 10 years if they don't get treated, It's quite different with prostate cancer. Many, if not most, men will live over 10 years with prostate cancer." - Harmon Eyre The cancer can be picked up early by doing a blood test called - Prostate Specific Antigen (PSA). Prostate Specific Antigen is specific to prostate gland and is found only in seminal fluid or blood. Interestingly PSA was first used in forensic investigation to confirm if a stain on an undergarment was semen or not. Its presence meant that the fluid that stained the garment was seminal in origin. If the cancer is picked up during a routine periodic check, a biopsy of the gland is advised to determine the aggressiveness of the tumour. The decision on how to treat the cancer is usually a decision that is taken by the treating Urologist. He determines by various tests the stage of the disease and decides on the line of treatment that is suitable for the patient. If the cancer is still in its early stages and the patient is relatively young and in good health, they are usually advised to undergo a ‘Radical Prostatectomy'. However if the patient has early disease but is in poor health - hormonal manipulation and radiotherapy may be a better option to avoid the risks of surgery. Cancer that have gone beyond the confines of the prostate gland and spread to other areas of the body are more advanced and may require treatment with hormones or removal of testis . This can help to slow or stop the spread of the disease. Over the last couple of decades much research involving the prostate cancer has taken place and the disease is better understood. We however still have not been able to answer the question about which cancers requires urgent treatment and which do not require treatment. The research in genetics and proteomics may help us answer this important question in the near future.
|
Latest Publication and Research on Prostate Cancer - Updated on 04/18/2013.
Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer. - Published by PubMed
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide. - Published by PubMed
Elevation of Receptor Tyrosine Kinases by Small Molecule AKT Inhibitors in Prostate Cancer Is Mediated by Pim-1. - Published by PubMed
Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. - Published by PubMed
Indole-3-carbinol and 3', 3'-diindolylmethane modulate androgen's effect on C-C chemokine ligand 2 and monocyte attraction to prostate cancer cells. - Published by PubMed
Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer. - Published by PubMed
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide. - Published by PubMed
Elevation of Receptor Tyrosine Kinases by Small Molecule AKT Inhibitors in Prostate Cancer Is Mediated by Pim-1. - Published by PubMed
Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. - Published by PubMed
Indole-3-carbinol and 3', 3'-diindolylmethane modulate androgen's effect on C-C chemokine ligand 2 and monocyte attraction to prostate cancer cells. - Published by PubMed
|
|
|
| Share it! |  |
 |
 |
 |
 |
 |
 |
Related Links
Prostatitis Symptom Score Calculator
Prostatitis is a painful inflammation of the prostate gland. Use this anonymous test to find out if you have symptoms of prostatitis and calculate ...
Check Your Prostate Gland
Self-assessment online questionnaire that gives an early warning for enlarged prostate gland that maybe due to Benign or cancerous ...
Prostate Cancer: Treatment Options
Patients with an early stage of prostate cancer are managed by observation of changing symptoms and disease ...
Quiz on Prostate Cancer
Prostate cancer is fast gaining as a common cancer form among men; more threatening since its symptoms often go unnoticed until it's too late. This ...
Tumor Markers For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive ...
Quiz on Cancer
As the second most leading cause of death worldwide, Cancer is a global burden. But did you know that cancer could be cured, and that too completely? ...
Trans-Urethral Resection of the Prostate
'Trans-Urethral Resection of Prostate' (acronym-TURP) is an endoscopic surgery for enlarged prostate. Understand this surgical procedure with ...
Andropause / Male Menopause
It is now accepted that males encounter 'andropause' leading to an array of symptoms, from feeling 'blue' to low ...
Top Ten Facts About Prostate Cancer
This is the most controversial cancer in both treatment and diagnosis. Read interesting facts about this ...
Spinal or Epidural anesthesia - Animation
Slides and animation on spinal and epidural anesthesia illustrating the essentials of the procedure for a patient to ...
Male Reproductive System - Animation
Interactive section of Medindia gives explanation about Male Reproductive System ...
Journey of the Male Sperm - Animation
Interactive section of Medindia explains the journey of the sperm from testis to the outside ...
Health Animation- Female Reproductive system - Animation
Interactive section of Medindia gives details regarding Female reproductive system showing how the sperm fetilize the ...
Breast Self Examination - Animation
Slides and animation of Breast Self Examination for early detection of breast cancer lumps in ...
Check Your Prostate Gland
Self-assessment online questionnaire that gives an early warning for enlarged prostate gland that maybe due to Benign or cancerous ...
Reproductive System
Reproductive System:Reproduction is one of the most important and fundamental properties of living organisms by which every kind of living organism ...
Urinary System
The kidneys, ureter, bladder and urethra helps in eliminating the waste products and helps maintain the acid base and fluid balance of the ...
Comment & Contribute
|
|
The big news in oncology has been Johnson and Johnson purchasing Cougar Biotechnology for $1 billion. They have just bought promising prostate cancer compound, abiraterone.
So look out for this oral drug.
Dr.Shroff
The data hasn't even been announced at ASCO yet, that's this weekend coming, so one can only speculate that suitors got a sneak peek of the data under an NDA. A billion dollars certainly gets attention and raises the ante for future small oncology biotech deals.